Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C
Clinical trial NCT02803138 · COMPLETED
Trial details
- NCT number
- NCT02803138
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-07
- Primary completion
- 2018-10-21
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.